Exhaled Breath Profiles Before, During and After Exacerbation of COPD: A Prospective Follow-Up Study

References

• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD (2017 Report) 2017. [cited 2019 May 3]. Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-prevention-copd/
   Google Scholar
• American Thoracic Society/European Respiratory Society Task Force. Standards for the Diagnosis and Management of Patients with COPD. 2004. [cited 2019 May 3]. Available from: http://www.ers-education.org/lrmedia/2004/pdf/44027.pdf
   Google Scholar
• Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387–395. doi:10.1136/thx.2003.008730.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. doi:10.1136/thorax.57.10.847.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931. doi:10.1136/thx.2005.040527.
   PubMed Web of Science ®Google Scholar
• Toy EL, Gallagher KF, Stanley EL, et al. The economic impact of exacerbations of chronic obstructive pulmonary disease and exacerbation definition: a review. COPD. 2010;7(3):214–228. doi:10.3109/15412555.2010.481697.
   PubMedGoogle Scholar
• Xu W, Collet JP, Shapiro S, et al. Negative impacts of unreported COPD exacerbations on health-related quality of life at 1 year. Eur Respir J. 2010;35(5):1022–1030. doi:10.1183/09031936.00079409.
   PubMed Web of Science ®Google Scholar
• Langsetmo L, Platt RW, Ernst P, et al. Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med. 2008;177(4):396–401. doi:10.1164/rccm.200708-1290OC.
   PubMed Web of Science ®Google Scholar
• Jones PW, Lamarca R, Chuecos F, et al. Characterisation and impact of reported and unreported exacerbations: results from ATTAIN. Eur Respir J. 2014;44(5):1156–1165. doi:10.1183/09031936.00038814.
   PubMed Web of Science ®Google Scholar
• Wilkinson TM, Donaldson GC, Hurst JR, et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004;169(12):1298–1303. doi:10.1164/rccm.200310-1443OC.
   PubMed Web of Science ®Google Scholar
• Celli BR, Decramer M, Wedzicha JA, et al. An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. Eur Respir Rev. 2015;24(136):159–172. doi:10.1183/16000617.00000315.
   PubMed Web of Science ®Google Scholar
• Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med. 2008;178(4):332–338. doi:10.1164/rccm.200712-1869OC.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD 2016. [cited 2019 May 3]. Available from: http://goldcopd.org/global-strategy-diagnosis-management-prevention-copd-2016/
   Google Scholar
• Horvath I, Barnes PJ, Loukides S, et al. A European Respiratory Society technical standard: exhaled biomarkers in lung disease. Eur Respir J. 2017;49(4). doi:10.1183/13993003.00965-2016.
   Web of Science ®Google Scholar
• Boots AW, Bos LD, van der Schee MP, et al. Exhaled molecular fingerprinting in diagnosis and monitoring: validating volatile promises. Trends Mol Med. 2015;21(10):633–644. doi:10.1016/j.molmed.2015.08.001.
   PubMed Web of Science ®Google Scholar
• Pizzini A, Filipiak W, Wille J, et al. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. J Breath Res.. 2018;12(3):036002. doi:10.1088/1752-7163/aaa4c5.
   PubMed Web of Science ®Google Scholar
• Shafiek H, Fiorentino F, Merino JL, et al. Using the electronic nose to identify airway infection during COPD exacerbations. PLoS One. 2015;10(9):e0135199. doi:10.1371/journal.pone.0135199.
   PubMed Web of Science ®Google Scholar
• van Geffen WH, Bruins M, Kerstjens HA. Diagnosing viral and bacterial respiratory infections in acute COPD exacerbations by an electronic nose: a pilot study. J Breath Res.. 2016;10(3):036001. doi:10.1088/1752-7155/10/3/036001.
   PubMed Web of Science ®Google Scholar
• Brinkman P, van de Pol MA, Gerritsen MG, et al. Exhaled breath profiles in the monitoring of loss of control and clinical recovery in asthma. Clin Exp Allergy. 2017;47(9):1159–1169. doi:10.1111/cea.12965.
   PubMed Web of Science ®Google Scholar
• van Velzen P, Ter Riet G, Bresser P, et al. Doxycycline for outpatient-treated acute exacerbations of COPD: a randomised double-blind placebo-controlled trial. Lancet Respir Med. 2017;5(6):492–499. doi:10.1016/S2213-2600(17)30165-0.
   PubMed Web of Science ®Google Scholar
• van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
   PubMedGoogle Scholar
• Kocks JW, Tuinenga MG, Uil SM, et al. Health status measurement in COPD: the minimal clinically important difference of the clinical COPD questionnaire. Respir Res. 2006;7(1):62. doi:10.1186/1465-9921-7-62.
   PubMed Web of Science ®Google Scholar
• Brinkman P, Wagener AH, Hekking PP, et al. Identification and prospective stability of electronic nose (eNose)-derived inflammatory phenotypes in patients with severe asthma. J Allergy Clin Immunol. 2019;143(5):1811–1820.e7. doi:10.1016/j.jaci.2018.10.058.
   PubMed Web of Science ®Google Scholar
• Ahmed WM, Brinkman P, Weda H, et al. Methodological considerations for large-scale breath analysis studies: lessons from the U-BIOPRED severe asthma project. J Breath Res. 2018;13(1):016001. doi:10.1088/1752-7163/aae557.
   PubMed Web of Science ®Google Scholar
• Lamote K, Brinkman P, Vandermeersch L, et al. Breath analysis by gas chromatography-mass spectrometry and electronic nose to screen for pleural mesothelioma: a cross-sectional case-control study. Oncotarget. 2017;8(53):91593–91602. doi:10.18632/oncotarget.21335.
   PubMedGoogle Scholar
• Bos LD, van Walree IC, Kolk AH, et al. Alterations in exhaled breath metabolite-mixtures in two rat models of lipopolysaccharide-induced lung injury. J Appl Physiol (Bethesda, MD: 1985). 2013;115(10):1487–1495. doi:10.1152/japplphysiol.00685.
   PubMed Web of Science ®Google Scholar
• Arasaradnam RP, McFarlane MJ, Ryan-Fisher C, et al. Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis. PLoS One. 2014;9(9):e108750. doi:10.1371/journal.pone.0108750.
   PubMed Web of Science ®Google Scholar
• Lewis NS. Comparisons between mammalian and artificial olfaction based on arrays of carbon black-polymer composite vapor detectors. Acc Chem Res. 2004;37(9):663–672. doi:10.1021/ar030120m.
   PubMed Web of Science ®Google Scholar
• Di Natale C, Paolesse R, D’Amico A. Metalloporphyrins based artificial olfactory receptors. Sens Actuators B Chem. 2007;121(1):238–246. doi:10.1016/j.snb.2006.09.038.
   Web of Science ®Google Scholar
• Smith CA, Want EJ, O'Maille G, et al. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem. 2006;78(3):779–787. doi:10.1021/ac051437y.
   PubMed Web of Science ®Google Scholar
• Gaugg MT, Nussbaumer-Ochsner Y, Bregy L, et al. Real-time breath analysis reveals specific metabolic signatures of COPD exacerbations. Chest. 2019;156(2):269. doi:10.1016/j.chest.2018.12.023.
   PubMed Web of Science ®Google Scholar
• Bos LD, Sterk PJ, Schultz MJ. Volatile metabolites of pathogens: a systematic review. PLoS Pathog. 2013;9(5):e1003311. doi:10.1371/journal.ppat.1003311.
   PubMed Web of Science ®Google Scholar
• Microbial volatile organic compound database 2.0. [cited 2019 May 3]. Available from: http://bioinformatics.charite.de/mvoc/index.php?site=home
   Google Scholar
• Phillips M, Herrera J, Krishnan S, et al. Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl. 1999;729(1–2):75–88. doi:10.1016/S0378-4347(99)00127-9.
   PubMedGoogle Scholar
• Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 1987;106(2):196–204. doi:10.7326/0003-4819-106-2-196.
   PubMed Web of Science ®Google Scholar